Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD

被引：3
|
作者：
Naguy, Ahmed [1 ]
机构：
[1] KCMH, Al Manara CAP Ctr, Shuwaikh, State Of Kuwait, Kuwait
来源：
JOURNAL OF NERVOUS AND MENTAL DISEASE | 2017年 / 205卷 / 09期
关键词：
PERVASIVE DEVELOPMENTAL DISORDERS; AUTISM SPECTRUM DISORDERS; CHILDREN; ATOMOXETINE;
D O I：
10.1097/NMD.0000000000000723
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：738 / 738
页数：1
相关论文
共 50 条
  • [31] Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan
    Wang, Liang-Jen
    Yang, Kang-Chung
    Lee, Sheng-Yu
    Yang, Chun-Ju
    Huang, Ting-Shuo
    Lee, Tung-Liang
    Yuan, Shin-Sheng
    Shyu, Yu-Chiau
    PLOS ONE, 2016, 11 (08):
  • [32] Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle
    Spencer, T
    Biederman, J
    Wilens, T
    Harding, M
    ODonnell, BAD
    Griffin, S
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1996, 35 (04): : 409 - 432
  • [33] Recent developments in the pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD)
    Brown, RT
    La Rosa, A
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2002, 33 (06) : 591 - 595
  • [34] Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder
    Biederman, J
    Spencer, T
    Wilens, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (01): : 77 - 97
  • [35] Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options
    Zavadenko, N. N.
    Solomasova, A. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (08) : 44 - 48
  • [36] Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
    Minzenberg, Michael J.
    NEUROTHERAPEUTICS, 2012, 9 (03) : 610 - 621
  • [37] Attention difficulties in comorbid autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD)
    Shahabuddin, A.
    Todd, J.
    Heinrich, K.
    Hodges, E.
    CLINICAL NEUROPSYCHOLOGIST, 2016, 30 (03) : 450 - 450
  • [38] Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder
    Coetzee, Corne
    Schellekens, Arnt F. A.
    Truter, Ilse
    Meyer, Anneke
    EUROPEAN ADDICTION RESEARCH, 2023, 29 (01) : 9 - 18
  • [39] Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder
    Biederman, J
    Wilens, T
    Mick, E
    Spencer, T
    Faraone, SV
    PEDIATRICS, 1999, 104 (02) : art. no. - e20
  • [40] Impulsive Aggression in Attention-Deficit/Hyperactivity Disorder: Symptom Severity, Co-Morbidity, and Attention-Deficit/Hyperactivity Disorder Subtype
    Connor, Daniel F.
    Chartier, Karen G.
    Preen, Ellen C.
    Kaplan, Richard F.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (02) : 119 - 126
12345